Question special
Lead Moderator

There seems to be a role for gene assays in prognosticating cancers associated with known genetic variants (e.g. breast cancer and BRCA). Is there a role for a similar assay for cancers instead strongly associated with tumorigenic environments, such as lung and bowel cancer?